Compounded low-dose atropine eye drops prepared per prescriber direction for individualized ophthalmic care. Prescription required.
Low Dose Naltrexone (LDN) Sublingual Drops are compounded by HDRx according to individualized prescriber specifications, including customized concentration and dosing instructions. A valid prescription from a licensed healthcare provider is required.
Naltrexone is classified as an opioid receptor antagonist. At lower doses, it may be incorporated into provider-directed care plans when clinically appropriate. The sublingual dosage form allows medication to be administered under the tongue, which may be considered when an alternative delivery route is preferred by a prescriber.
LDN is frequently discussed in clinical settings involving chronic and complex care planning. For additional educational context, explore our resources on LDN and chronic pain discussions, LDN in autoimmune-related care planning, our broader overview of LDN compounding services, and perspectives on LDN in autoimmune discussions.
For related care considerations, you may also explore mast cell stabilization discussions in MCAS and provider-directed planning for post-acute withdrawal syndrome (PAWS).
Learn more about HDRx’s approach on our dedicated LDN service page.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs. Patients should consult their licensed healthcare provider to determine whether LDN is appropriate for their individual condition.
